[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
[ Fri, May 12th 2023 ]: WOPRAI
David Nierengarten Reiterated (ANAB) at Hold and Held Target at $29 on, May 12th, 2023
- 🞛 This publication is a summary or evaluation of another publication
David Nierengarten of Wedbush, Reiterated "AnaptysBio, Inc." (ANAB) at Hold and Held Target at $29 on, May 12th, 2023.
David has made no other calls on ANAB in the last 4 months.
There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Anupam Rama of "JP Morgan" Maintained at Sell with Decreased Target to $31 on, Wednesday, April 12th, 2023